Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
14 Results for "
Bcl-x
" in MedChemExpress (MCE) Product Catalog:
Products (14)
14 Results for "Bcl-x" in MCE Product Catalog:
1
Cat. No.: HY-170935
SRSF1-IN-1 is a SRSF1 inhibitor. SRSF1-IN-1 inhibits SRSF1 expression, thereby modulating the splicing of Bcl-x pre-mRNA. SRSF1-IN-1 inhibits the proliferation of various cancer cells. SRSF1-IN-1 induces apoptosis in gastric cancer cells, reduces Bcl-xl expression, and upregulates cleaved PARP and caspase 3. SRSF1-IN-1 induces autophagy and promotes cell death. SRSF1-IN-1 exhibits anti-tumor activity in a mouse gastric cancer xenograft model. SRSF1-IN-1 can be used for the research of various cancers including liver cancer, gastric cancer, breast cancer, colon cancer, glioma, and melanoma .
Cat. No.: HY-P2040
CAS No.: 118399-22-7
Cat. No.: HY-P72846A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Bcl2L1; Bcl-X; Bcl2 Like 1; Protein Phosphatase 1, Regulatory Subunit 52; Bcl2L; Bcl-XL; BclX; Bcl-XS; Apoptosis Regulator Bcl-X; Bcl-XL/S; Bcl-2-Like Protein 1; Bcl2-L-1; PPP1R52
Cat. No.: HY-RS01423
Research Areas:
Bcl2l1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS01421
Research Areas:
BCL2L1 Human Pre-designed siRNA Set A contains three designed siRNAs for BCL2L1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS01422
Research Areas:
Bcl2l1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bcl2l1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-15867
CAS No.: 1020210-12-1
Synonyms: (+)-Meayamycin B
Target:
Research Areas:
Meayamycin B ((+)-Meayamycin B) is a potent SF3B1 inhibitor. Meayamycin B upregulates the proapoptotic Mcl-1S and downregulates Mcl-1L at the pre-mRNA splicing level. Meayamycin B does not regulate the alternative splicing of Bcl-x. Meayamycin B and ABT-737 (HY-50907) synergistically causes Apoptosis. Meayamycin B exhibits anticancer activity against non-small cell lung cancer .
Cat. No.: HY-P702954
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: BAD; Bcl-2-Like Protein 8; Bcl2 Associated Agonist Of Cell Death; Bcl2-L-8; Bcl2L8; Bcl2-Antagonist Of Cell Death Protein; BBC2; Bcl-X/Bcl-2 Binding Protein; Bcl-XL/Bcl-2-Associated Death Promoter; Bcl2-Binding Component 6; Bcl2-Associated Agonist Of Cell
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
